A detailed history of Ubs Asset Management Americas Inc transactions in Liva Nova PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 122,740 shares of LIVN stock, worth $5.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,740
Previous 63,933 91.98%
Holding current value
$5.74 Million
Previous $3.5 Million 83.93%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.38 - $54.59 $2.55 Million - $3.21 Million
58,807 Added 91.98%
122,740 $6.45 Million
Q2 2024

Aug 13, 2024

SELL
$51.76 - $64.15 $13.6 Million - $16.9 Million
-263,706 Reduced 80.49%
63,933 $3.5 Million
Q1 2024

May 15, 2024

SELL
$48.6 - $57.12 $21.2 Million - $24.9 Million
-436,633 Reduced 57.13%
327,639 $18.3 Million
Q4 2023

Feb 14, 2024

SELL
$43.45 - $53.66 $6.15 Million - $7.59 Million
-141,458 Reduced 15.62%
764,272 $39.5 Million
Q3 2023

Nov 13, 2023

BUY
$50.12 - $58.87 $958,444 - $1.13 Million
19,123 Added 2.16%
905,730 $47.9 Million
Q1 2023

May 15, 2023

SELL
$40.84 - $58.14 $1.49 Million - $2.13 Million
-36,577 Reduced 3.96%
886,607 $38.6 Million
Q4 2022

Feb 14, 2023

SELL
$43.88 - $56.16 $1.83 Million - $2.34 Million
-41,602 Reduced 4.31%
923,184 $51.3 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $2.73 Million - $3.75 Million
-56,360 Reduced 5.52%
964,786 $49 Million
Q2 2022

Aug 12, 2022

BUY
$57.25 - $86.63 $1.7 Million - $2.57 Million
29,609 Added 2.99%
1,021,146 $63.8 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $2.44 Million - $2.99 Million
34,321 Added 3.59%
991,537 $81.1 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $13.9 Million - $16.7 Million
180,701 Added 23.27%
957,216 $83.7 Million
Q3 2021

Nov 15, 2021

SELL
$76.02 - $88.62 $714,511 - $832,939
-9,399 Reduced 1.2%
776,515 $61.5 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $14.5 Million - $17.2 Million
-197,679 Reduced 20.1%
785,914 $66.1 Million
Q1 2021

May 14, 2021

SELL
$62.9 - $82.41 $2.98 Million - $3.9 Million
-47,328 Reduced 4.59%
983,593 $72.5 Million
Q4 2020

Mar 01, 2021

BUY
$46.01 - $68.74 $7.6 Million - $11.3 Million
165,114 Added 19.07%
1,030,921 $68.3 Million
Q3 2020

Nov 13, 2020

BUY
$41.91 - $57.81 $656,981 - $906,229
15,676 Added 1.84%
865,807 $39.1 Million
Q2 2020

Aug 14, 2020

SELL
$39.87 - $56.9 $24.6 Million - $35.1 Million
-616,566 Reduced 42.04%
850,131 $40.9 Million
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $9.85 Million - $22 Million
-287,753 Reduced 16.4%
1,466,697 $66.4 Million
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $477,891 - $591,262
-6,934 Reduced 0.39%
1,754,450 $132 Million
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $26.6 Million - $32 Million
371,085 Added 26.69%
1,761,384 $130 Million
Q2 2019

Aug 15, 2019

BUY
$66.45 - $97.36 $17.2 Million - $25.3 Million
259,369 Added 22.93%
1,390,299 $0
Q1 2019

May 14, 2019

SELL
$86.15 - $100.49 $3.87 Million - $4.51 Million
-44,865 Reduced 3.82%
1,130,930 $0
Q4 2018

Feb 13, 2019

SELL
$84.14 - $125.42 $7.97 Million - $11.9 Million
-94,676 Reduced 7.45%
1,175,795 $108 Million
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $7.54 Million - $9.77 Million
74,620 Added 6.24%
1,270,471 $0
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $26 Million - $33.5 Million
318,012 Added 36.23%
1,195,851 $0
Q1 2018

May 14, 2018

BUY
$79.95 - $89.74 $68.3 Million - $76.7 Million
854,871 Added 3722.01%
877,839 $0
Q4 2017

Feb 09, 2018

BUY
$71.8 - $88.21 $230,549 - $283,242
3,211 Added 16.25%
22,968 $0
Q3 2017

Nov 13, 2017

BUY
$60.32 - $70.06 $1.19 Million - $1.38 Million
19,757
19,757 $0

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.